S&P 500
(0.31%) 5 115.94 points
Dow Jones
(0.30%) 38 355 points
Nasdaq
(0.36%) 15 986 points
Oil
(-0.98%) $83.03
Gas
(5.36%) $2.03
Gold
(0.34%) $2 355.10
Silver
(0.51%) $27.68
Platinum
(4.20%) $960.80
USD/EUR
(-0.27%) $0.932
USD/NOK
(-0.44%) $10.98
USD/GBP
(-0.58%) $0.796
USD/RUB
(1.63%) $93.37

リアルタイムの更新: Meridian Bioscience Inc [VIVO]

取引所: NASDAQ セクター: Healthcare 産業: Diagnostics & Research
最終更新日時31 1月 2023 @ 06:00

0.00% $ 33.97

Live Chart Being Loaded With Signals

Commentary (31 1月 2023 @ 06:00):
Profile picture for Meridian Bioscience Inc

Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide...

Stats
本日の出来高 5.63M
平均出来高 686 607
時価総額 1.49B
EPS $0 ( 2023-05-04 )
Last Dividend $0.125 ( 2019-02-01 )
Next Dividend $0 ( N/A )
P/E 21.09
ATR14 $0.299 (0.88%)
Insider Trading
Date Person Action Amount type
2023-01-31 Williams Felicia Sell 10 274 Common Stock
2023-01-31 Williams Felicia Sell 12 000 Stock Option (Right to Buy)
2023-01-31 Williams Felicia Sell 8 740 Stock Option (Right to Buy)
2023-01-31 Williams Felicia Sell 17 205 Stock Option (Right to Buy)
2023-01-31 Williams Felicia Sell 5 796 Stock Option (Right to Buy)
INSIDER POWER
-88.83
Last 100 transactions
Buy: 118 571 | Sell: 1 534 678

ボリューム 相関

長: 0.42 (neutral)
短: 0.51 (weak)
Signal:(71.236) Neutral

Meridian Bioscience Inc 相関

10 最も正の相関
TCAC0.987
TCACU0.946
GLAQ0.82
ENVIU0.819
10 最も負の相関
KRBP-0.99
RICO-0.904
ORTX-0.817

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Meridian Bioscience Inc 相関 - 通貨/商品

The country flag 0.25
( neutral )
The country flag 0.76
( moderate )
The country flag 0.00
( neutral )
The country flag 0.59
( weak )
The country flag -0.72
( moderate negative )
The country flag -0.22
( neutral )

Meridian Bioscience Inc 財務諸表

Annual 2022
収益: $333.02M
総利益: $188.36M (56.56 %)
EPS: $0.960
FY 2022
収益: $333.02M
総利益: $188.36M (56.56 %)
EPS: $0.960
FY 2021
収益: $317.90M
総利益: $201.15M (63.27 %)
EPS: $1.650
FY 2020
収益: $253.67M
総利益: $156.25M (61.60 %)
EPS: $1.080

Financial Reports:

No articles found.

Meridian Bioscience Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Meridian Bioscience Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0.950 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.00678 1990-11-29
Last Dividend $0.125 2019-02-01
Next Dividend $0 N/A
Payout Date 2019-02-14
Next Payout Date N/A
# dividends 114 --
Total Paid Out $9.88 --
Avg. Dividend % Per Year 0.00% --
Score 2.53 --
Div. Sustainability Score 0.950
Div.Growth Potential Score 0
Div. Directional Score 0.115 --
Next Divdend (Est)
(2024-07-17)
$0 Estimate 0.00 %
Dividend Stability
0.17 Bad
Dividend Score
2.53
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
1990 $0 0.00%
1991 $0 0.00%
1992 $0 0.00%
1993 $0 0.00%
1994 $0 0.00%
1995 $0 0.00%
1996 $0 0.00%
1997 $0 0.00%
1998 $0 0.00%
1999 $0 0.00%
2000 $0 0.00%
2001 $0 0.00%
2002 $0 0.00%
2003 $0.160 3.50%
2004 $0.178 3.83%
2005 $0.213 2.70%
2006 $0.307 2.09%
2007 $0.434 2.63%
2008 $0.560 1.88%
2009 $0.680 2.60%
2010 $0.760 3.51%
2011 $0.760 3.21%
2012 $0.950 4.98%
2013 $0.570 2.75%
2014 $0.800 3.06%
2015 $0.800 4.88%
2016 $0.800 4.10%
2017 $0.500 2.80%
2018 $0.500 3.47%
2019 $0.125 0.74%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.1971.500-3.93-5.90[0 - 0.5]
returnOnAssetsTTM-0.05281.200-1.760-2.11[0 - 0.3]
returnOnEquityTTM-0.06811.500-1.867-2.80[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM2.560.8002.181.741[1 - 3]
quickRatioTTM1.4720.8006.054.84[0.8 - 2.5]
cashRatioTTM0.9431.5005.878.81[0.2 - 2]
debtRatioTTM0.0682-1.5008.86-10.00[0 - 0.6]
interestCoverageTTM-65.481.000-10.00-10.00[3 - 30]
operatingCashFlowPerShareTTM-0.008252.00-0.00275-0.00550[0 - 30]
freeCashFlowPerShareTTM-0.1482.00-0.0740-0.148[0 - 20]
debtEquityRatioTTM0.0914-1.5009.63-10.00[0 - 2.5]
grossProfitMarginTTM0.5341.0004.434.43[0.2 - 0.8]
operatingProfitMarginTTM-0.1971.000-5.93-5.93[0.1 - 0.6]
cashFlowToDebtRatioTTM-0.01161.000-1.176-1.176[0.2 - 2]
assetTurnoverTTM0.2680.800-1.544-1.235[0.5 - 2]
Total Score0.950

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-61.831.000-6.350[1 - 100]
returnOnEquityTTM-0.06812.50-1.200-2.80[0.1 - 1.5]
freeCashFlowPerShareTTM-0.1482.00-0.0493-0.148[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-0.008252.00-0.00275-0.00550[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM1.5181.5003.220[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.002951.000-2.570[0.1 - 0.5]
Total Score-0.720

Meridian Bioscience Inc

Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare brands; and urea breath testing for H. pylori under the BreathID and BreathTek brand. This segment also offers respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry products for LeadCare test kits for the detection of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。